ARCHIVES

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

This article is from The Cancer Letter archive.

Vol. 12 No. 21 | May 23, 1986

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

New Cyclotron Delivered To University of Maryland, Instigating D.C.-Area Proton Radiation Competition

June 20, 2014

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990